在帕金森病风险中的罕见SV2C编码变体
Chu Hua Chang1,2, Elaine Guo Yan Chew1, Michelle Mulan Lian1
1Lee Kong Chian School of Medicine, Nanyang Technological University Singapore, Singapore, Singapore.
Journal of Parkinson's disease
|February 20, 2025
概括
除了已知的常见变异外,突触囊泡糖蛋白2C (SV2C) 的罕见编码变异不会显著增加东亚人口的帕金森病 (PD) 风险. 这项研究调查了SV2C在PD易感性中的作用.
科学领域:
- 遗传学 遗传学 是一个
- 神经科学是一个神经科学.
- 分子生物学分子生物学
背景情况:
- 全基因组关联研究确定了SV2C作为帕金森病 (PD) 风险位置.
- 在SV2C中,一个常见的误解变体 (p.Asp543Asn) 与PD有显著的关联.
- 其他罕见的SV2C变异在PD易感性中的作用尚不清楚.
研究的目的:
- 调查SV2C中罕见的编码变体与帕金森病风险的关联.
- 为了确定罕见的SV2C变异是否有助于东亚人口的PD易感性.
主要方法:
- 分析了来自9810名东亚人 (PD患者4298人,对照5512人) 的全外因子测序数据.
- 在SV2C中对55种罕见的非同义变异进行识别和关联测试.
- 评估罕见的非同义和功能丧失变体的PD关联.
主要成果:
- 在SV2C中发现了55种罕见的非同义变异.
- 在罕见的非同义或功能丧失的SV2C变体和PD之间没有发现显著的关联.
- 常见的p.Asp543Asn变体仍然是主要的SV2C相关的PD风险因素.
结论:
- 在SV2C中罕见的编码变体似乎在东亚的帕金森病易感性中没有发挥重要作用.
- 在这个人群中,p.Asp543Asn变异是PD的主要SV2C相关风险因素.
- 进一步的研究可能会关注其他影响PD风险的遗传或环境因素.
相关概念视频
Comparing Copy Number Variations and SNPs
17.0K
Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
17.0K
Single Nucleotide Polymorphisms-SNPs
13.9K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
13.9K
Parkinson's Disease: Overview
429
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
429
Neural Regulation
39.1K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.1K
Genome-wide Association Studies-GWAS
12.3K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
12.3K
Parkinson's Disease: Treatment
187
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
187


